Admera Health becomes a PacBio Certified Service Provider

Admera Health has earned PacBio Certified Service Provider status and added Revio HiFi long-read sequencing to its U.S.-based genomics menu. The move expands the company’s end-to-end sequencing offering for researchers studying structural variants, transcript isoforms and other complex genomic questions.

Why it matters: - Admera Health now offers PacBio HiFi long-read sequencing alongside its short-read services, giving researchers one U.S.-based provider for more of the genomic workflow. - The certification is aimed at studies that need higher-confidence resolution of structural variants, repetitive regions, haplotype phasing and isoform-level transcript profiling. - The expansion strengthens Admera Health’s position with pharmaceutical, biotech, academic and translational research partners seeking higher-resolution genomic data.

What happened: - Admera Health announced on July 29, 2026, that it has become a PacBio Certified Service Provider. - The certification includes the Revio™ high-throughput sequencing system and HiFi long-read sequencing services. - The company said the status makes it one of the few U.S. providers able to deliver end-to-end short-read and long-read NGS services entirely in the U.S.

The details: - PacBio HiFi sequencing combines long reads with base-level accuracy. - Admera Health says the platform supports whole genome sequencing, Iso-Seq full-length transcriptome analysis, structural variant detection, metagenomics, microbial genomics, rare disease research and oncology research. - The Revio system increases sequencing capacity while maintaining HiFi read accuracy. - Admera Health says the service gives clients faster turnaround times and more cost-efficient long-read sequencing. - The company operates CLIA-certified and CAP-accredited infrastructure. - Admera Health says all samples and datasets stay on U.S. soil, with no overseas shipping or data residency concerns. - The company says it provides dedicated project management and bioinformatics support from sample intake through final dataset delivery. - Admera Health said its full NGS portfolio now spans short-read and long-read sequencing under one roof.

Between the lines: - The certification signals that long-read sequencing is moving closer to routine use in applied genomics, not just specialized research settings. - Keeping sequencing, data handling and support inside the U.S. may appeal to organizations with compliance or data-security requirements. - The combination of clinical-grade infrastructure and broader sequencing breadth is a competitive differentiator in a crowded services market.

What's next: - Admera Health is positioning the new service for ongoing work with biopharma, academic and translational research customers. - The company is directing researchers to its long-read sequencing page for more information: PacBio Revio HiFi sequencing services. - The company is also likely to use the certification to broaden adoption of its long-read offerings across discovery and development programs.